Integra LifeSciences Holdings Corporation logo IART - Integra LifeSciences Holdings Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 11
HOLD 10
SELL 5
STRONG
SELL
0
| PRICE TARGET: $12.00 DETAILS
HIGH: $12.00
LOW: $12.00
MEDIAN: $12.00
CONSENSUS: $12.00
DOWNSIDE: 19.38%

About Integra LifeSciences Holdings Corporation (https://www.integralife.com)

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Key Executives

NAME TITLE DOB SALARY
Mojdeh Poul President, Chief Executive Officer & Director 1963 $1,905,673 USD
Michael J. McBreen Chief Commercial Officer 1966 $942,931 USD
Lea Daniels Knight Executive Vice President & Chief Financial Officer 1973 $884,701 USD
Robert T. Davis Jr. Executive Vice President & President of Tissue Technologies 1959 $722,354 USD
Harvinder Singh Executive Vice President & President of International Business 1966 $714,613 USD
Michael D. Hutchinson Executive Vice President, Chief Legal Officer & Secretary 1971 $549,518 USD
Jeffrey Mosebrook Senior Vice President of Finance & Principal Accounting Officer 1976 $493,138 USD
Stuart Essig CEO, President & Chairman 1962 $85,000 USD
Chantal Veillon-Berteloot Executive Vice President & Chief Human Resources Officer 1971
Christopher Ward Senior Director of Investor Relations
Jessica Smith Corporate VP & Global Quality and Chief Regulatory Officer
Laurene Isip Vice President of Global Corporate Communications & Public Relations
Teshtar Elavia Corporate VP & Chief Technology Officer

Company Peers

Peer analysis pending, check back in 1-2 minutes.